Movement Alert｜WUXI BIO falls 3.12% in Regular Trading, trading at HK$47.94

Market Focus10-22

On October 22, WUXI BIO fell 3.12% in Regular Trading, trading at HK$47.94, with turnover of HK$322 million.

Within the Life Sciences Tools & Services sector where WUXI BIO belongs, peer moves were mostly weaker: GENSCRIPT B-1K fell 0.06%, WUXI APPTEC fell 1.79%, INSILICO fell 5.8%, WUXI XDC fell 2.56%, and XTALPI fell 2.54%.

Company profile: WUXI BIO is an investment holding company principally engaged in end-to-end solutions for biologics discovery, development and manufacturing. It operates through the Biologics segment and the XDC segment, providing CRDMO services for biologics, ADCs and other bioconjugates across domestic and overseas markets.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment